The Methode Collective Member Rate: $40, Non-Member $75

Members join via our online group.
Want to join the collective? Click here!

Not a member? Join our webinar here!

Monday June 1st 7pm CST/5pm PST

Here's what you'll learn:

• Course Description

  This continuing education webinar provides a comprehensive review of the legal, regulatory, and ethical considerations essential to safe and compliant practice in medical aesthetics. Led by Alice Tudor, CRNA, this session explores key principles of scope of practice, documentation standards, informed consent, and risk mitigation strategies, with additional focus on regulatory considerations related to peptides and injectable treatments.

  As the field of aesthetic medicine continues to evolve, providers must navigate increasingly complex regulatory frameworks, including distinctions between FDA-approved, compounded, and research-use substances. This activity is designed to strengthen clinical decision-making through a deeper understanding of legal and compliance standards, helping providers reduce liability while maintaining ethical, patient-centered care.

  Participants will engage in a structured review of:

  • Scope of practice considerations across licensure levels

  • Legal responsibilities and regulatory oversight in aesthetic practice

  • Regulatory classifications of peptides, including FDA-approved, compounded, and research-use substances

  • Documentation standards and informed consent requirements

  • Risk management strategies to support safe and compliant care

  • Common areas of legal vulnerability in medical aesthetics

  This activity is intended for licensed healthcare professionals involved in aesthetic practice, including registered nurses and advanced practice providers.

  Learning Objectives

  Upon completion of this activity, the learner will be able to:

  1. Identify scope of practice parameters relevant to aesthetic providers based on licensure and regulatory standards

  2. Differentiate regulatory classifications of peptides, including FDA-approved, compounded, and research-use substances, and their implications for clinical practice

  3. Describe key legal and ethical responsibilities associated with aesthetic practice, including informed consent and documentation requirements

  4. Recognize common areas of legal risk and vulnerability in medical aesthetics, particularly related to injectable treatments and emerging therapies

  5. Apply risk management strategies to support safe, compliant, and ethical patient care

  6. Integrate legal and regulatory knowledge into clinical decision-making to reduce liability and improve practice standards

  🫱🏼‍🫲🏽In an effort to foster connection and create a more engaged learning environment, we encourage participants to keep their cameras on when possible.

  • If you are driving or otherwise unable, please prioritize your safety.

  • We also ask that you update your Zoom display name to reflect your name, rather than “iPhone” or “Zoom User,” so we can better connect with one another throughout the session.

Kamilla + Bree

Co-Founders of the Methode Collective